CBZ Stock Analysis: Buy, Sell, or Hold?
CBZ - CBIZ, Inc.
$30.40
1.74 (6.07%)
β²
5d:
-10.32%
30d:
-5.18%
90d:
+13.9%
WAIT
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Jul 29, 2026
Get Alerted When CBZ Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: CBZ is down 10.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: CBZ is down 10.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$56.05
Based on 7.2% avg growth
INTRINSIC VALUE TODAY
$34.80
12.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CBZ is currently trading at $30.40, which is considered oversold relative to its 30-day fair value range of $30.85 to $34.16. From a valuation perspective, the stock is trading at a discount (Forward PE: 6.4) compared to its historical average (8.8). Remarkably, the market is currently pricing in an annual earnings decline of 10.0% over the next few years. This pessimistic expectation contrasts with the company's recent 37.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, CBZ is showing sideways momentum. Immediate support is located at $27.85, while resistance sits at $35.67. The stock is showing strong short-term momentum, up 6.1% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $41.00 (+43.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CBZ is showing sideways momentum. Immediate support is located at $27.85, while resistance sits at $35.67. The stock is showing strong short-term momentum, up 6.1% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $41.00 (+43.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$30.85 -
$34.16
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.3%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.1%)
- BULLISH: Trading 43.1% below Wall St target ($41.00)
- WARNING: Recommendation downgraded due to -10.3% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$30.85 -
$34.16
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$27.85
Resistance Level
$35.67
Current Trend
Sideways
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.38
Wall Street Target
$41.00
(+43.1%)
Revenue Growth (YoY)
1.3%
Earnings Growth (YoY)
37.7%
Profit Margin
5.6%
Valuation Discount vs History
-10.0% cheaper
PE vs Historical
6.4 vs 8.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-10.0%
(market-implied from PE analysis)
1-Year Target
$25.79
(-10%)
2-Year Target
$23.21
(-19%)
3-Year Target
$20.89
(-27%)
3-Yr Target (if PE normalizes)
(PE: 6β9)
$28.83
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 10.5%)
$132.06
(+361%)
Base:
(SPY PE: 6.4, Growth: 10.5%)
$38.67
(+35%)
Bear:
(PE: 5.4, Growth: 10.5%)
$32.87
(+15%)
π
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (12x PE), but valuation improves significantly next year (6x PE) as earnings recover.
Trailing PE: 12.20 | Current EPS (TTM): $2.55
Bull Case
$60.29
(+110%)
Analyst growth 76.2%, PE expands to 13.4
Base Case
$54.81
(+91%)
Market implied 76.2%, PE stable at 12.2
Bear Case
$21.15
(-26%)
Severe decline -20.0%, PE contracts to 10.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
π‘
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.4 to 8.8
Stabilization Target:
$39.55
(+38.0%)
PE Expansion Potential:
+38.0%
Share & Embed Analysis
Last updated: June 23, 2026 4:38 PM ET
Data refreshes hourly during market hours. Next update: 5:38 PM
Data refreshes hourly during market hours. Next update: 5:38 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CBZ showing a specific setup today?
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
NEUTRAL
Recent Transactions
Brad S Lakhia
BUY
12775 shares
2026-03-13
Josh Gottheimer
SELL
2026-03-05
Top Rated Specialty Business Services Stocks
Top-rated stocks in Specialty Business Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GPN
Global Payments Inc |
HOLD
33 analysts |
$95 | 52 HOLD |
|
ARMK
Aramark Holdings |
STRONG BUY
14 analysts |
$57 | 60 HOLD |
|
TRI
Thomson Reuters Corporat⦠|
STRONG BUY
18 analysts |
$123 | 49 HOLD |
|
CTAS
Cintas Corporation |
HOLD
21 analysts |
$211 | 61 BUY |
|
RBA
RB Global Inc. |
STRONG BUY
10 analysts |
$128 | 62 BUY |